PNB Housing Finance Q2 Results: Profit Up 23%, Asset Quality Improves
PNB Housing Finance reported a net profit of Rs 470 crore for the quarter ended September, up 23% year-on-year and 9% on a sequential basis to Rs 472 crore, led by improvement in asset quality.
The gross non-performing assets ratio of the company was 1.24% as of September, lower than 1.35% a quarter ago and 1.78% a year ago. Net NPA also improved to 0.84% as against 0.92% a quarter ago and 1.19% a year ago.
Healthy growth in assets under management also aided its bottomline. AUM recorded a growth of 11% on year and 3% on quarter to Rs 74,724 crore.
PNB Housing Finance Q2 Highlights (Consolidated, YoY)
Total income rises 5.7% at Rs 1,869 crore versus Rs 1,768 crore.
Net profit rises 22.7% at Rs 472 crore versus Rs 384 crore.
Meanwhile, retail disbursements grew by 28% on year to Rs 5,341 crore. Of this, affordable and emerging markets accounted for 31%.
As of Sept. 30, retail loan assets were Rs 67,970 crore. Affordable and emerging markets form 23% of the retail loan asset.
Corporate loans fell 36% on year to Rs 1,531 crore at the end of Sept. 30.
Slower growth in the non-bank lender's net interest income was due to the declining impact of its corporate book. The NII rose 1.2% on a yearly basis and 2.7% quarter-on-quarter to Rs 669 crore.
Additionally, the net interest margin of the housing financier was 3.68% in the September quarter as compared to 3.65% a quarter ago and 3.95% a year ago.
With recovery from the retail written-off pool, the credit cost of the housing financier was down by 24 basis points in the September quarter as compared to a 7 bps fall a quarter ago and a 26 bps rise a year ago.
During Jul-Sep, PNB Housing Finance recovered Rs 48 crore from the retail written-off pool.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.
-
You May Inherit The Business. You Must Earn Its Credibility.
Succession tests the founder's ability to share authority as much as it tests the next generation's readiness to assume it.
-
Signing Deals Is One Thing; Making Them Work Is Another | The Week In Whys
Sometimes, things don't turn out as planned. Indian companies have lost some bids to rivals, some projects won't produce until 2030.
-
FOMC Wall, PERM Suspension, Hospital Stocks | Talking Points This Week
A PERM suspension would directly affect green-card sponsorship rather than H-1B visas, so the near-term earnings impact could remain relatively limited. The key question is whether this marks a new phase in US scrutiny of Indian IT.
-
Everything, Everywhere, All At Once: Dalal Street's Week To Forget | Joining The Dots
Visa curbs, a Starlink spat and cancer drug caps: what connects this week's shocks for Indian markets